BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29636196)

  • 1. RF-Topical Rapamycin as an Adjuvant to Laser Treatment in Capillary Malformations.
    Alegre-Sánchez A; Boixeda P
    Actas Dermosifiliogr (Engl Ed); 2018 Dec; 109(10):915-916. PubMed ID: 29636196
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed ulceration following combination pulse dye laser and topical sirolimus treatment for port wine birthmarks: A case series.
    Hobayan CGP; Nourse EJ; Paradiso MM; Fernandez Faith E
    Pediatr Dermatol; 2024; 41(1):108-111. PubMed ID: 37571864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial.
    Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
    J Am Acad Dermatol; 2015 Jan; 72(1):151-8.e1. PubMed ID: 25455610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results.
    Bloom BS; Nelson JS; Geronemus RG
    J Am Acad Dermatol; 2015 Aug; 73(2):e71. PubMed ID: 26184004
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to: "Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results".
    Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
    J Am Acad Dermatol; 2015 Aug; 73(2):e73-4. PubMed ID: 26184005
    [No Abstract]   [Full Text] [Related]  

  • 6. Capillary Malformations Treated With Sequential Pulsed Dye and Nd:YAG Laser Therapy: A Retrospective Study.
    Alcántara-González J; Boixeda P; Truchuelo-Díez MT; Jiménez-Gómez N; Pérez-García B; Pérez-Carmona L; Jaén Olasolo P
    Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):155-161. PubMed ID: 29183621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary Malformation in CLAPO Syndrome Successfully Treated with Pulsed Dye Laser.
    Cerejeira D; Vergara-de-la-Campa L; Boixeda P; López-Gutiérrez JC
    Actas Dermosifiliogr; 2022 May; 113(5):505-509. PubMed ID: 35292145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of capillary malformations in capillary malformation-arteriovenous malformation syndrome with pulsed dye laser.
    Ang YS; Koh MJA
    J Cosmet Dermatol; 2021 Nov; 20(11):3710-3711. PubMed ID: 33655684
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant Topical Sirolimus for Pulsed Dye Laser in Pediatric Capillary Malformation.
    Gu Y; Sebaratnam DF
    Dermatol Surg; 2024 Mar; 50(3):300-301. PubMed ID: 38051197
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of capillary malformation using topical timolol combined with 585-nm pulsed dye laser: a prospective, randomized, split-lesion study.
    Cheon SJ; Shim WH; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):e328-e329. PubMed ID: 28079942
    [No Abstract]   [Full Text] [Related]  

  • 11. Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment.
    Griffin TD; Foshee JP; Finney R; Saedi N
    Lasers Surg Med; 2016 Feb; 48(2):193-6. PubMed ID: 26503090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone.
    Musalem HM; Alshaikh AA; Tuleimat LM; Alajlan S
    Ann Saudi Med; 2018; 38(5):376-380. PubMed ID: 30284993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.
    Greveling K; Prens EP; van Doorn MB
    Lasers Surg Med; 2017 Jan; 49(1):104-109. PubMed ID: 27320685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation.
    Doh EJ; Ohn J; Kim MJ; Kim YG; Cho S
    J Dermatolog Treat; 2017 Nov; 28(7):672-677. PubMed ID: 28285560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed dye laser-resistant capillary malformation treated using intradermal sclerotherapy with ethanolamine oleate after intense pulsed light treatment.
    Hwang SW; Lee HJ; Hong SK; Seo JK; Lee D; Sung H
    Dermatol Surg; 2010 Nov; 36(11):1775-8. PubMed ID: 20868377
    [No Abstract]   [Full Text] [Related]  

  • 16. Capillary malformation--arteriovenous malformation syndrome: review of the literature, proposed diagnostic criteria, and recommendations for management.
    Orme CM; Boyden LM; Choate KA; Antaya RJ; King BA
    Pediatr Dermatol; 2013; 30(4):409-15. PubMed ID: 23662773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application.
    Artzi O; Mehrabi JN; Heyman L; Friedman O; Mashiah J
    Dermatol Ther; 2020 Jan; 33(1):e13172. PubMed ID: 31747115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capillary malformation-arteriovenous malformation syndrome].
    Galán-Gutiérrez M; Ruiz-Villaverde R
    An Pediatr (Barc); 2013 Dec; 79(6):374-6. PubMed ID: 23608018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good response to pulsed dye laser in patients with capillary malformation-arteriovenous malformation syndrome (CM-AVM).
    Iznardo H; Roé E; Puig L; Vikula M; López-Sánchez C; Baselga E
    Pediatr Dermatol; 2020 Mar; 37(2):342-344. PubMed ID: 31944370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis caused by topical sirolimus used as an adjuvant for laser treatment of port wine stains.
    Greveling K; Kunkeler AC; Prens EP; van Doorn MB
    Contact Dermatitis; 2016 Sep; 75(3):184-5. PubMed ID: 27480514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.